COVID-19 Slows Drug Studies, Curbs Clinical Trials

Most studies not considered critical are being deferred. This won’t have much effect in the short term, but if this continues, it could delay patient care and the federal approval of drugs that treat a wide range of conditions.

from WebMD Health https://ift.tt/2Ux9oyD